CCNB1 and cancer: Consistent with the microtubule‐targeting activity of VU‐0365114, cancer cells with higher levels of mitotic regulators (CDK1, CCNB1, and STMN1) were more sensitive to VU‐0365114 (Table 1, Fig. 9A).